Scilex Inks Distribution Agreement For Neuropathic Painkiller ZTlido In The Middle East And North Africa

Scilex Holding Company SCLX, a majority-owned subsidiary of Sorrento Therapeutics, Inc SRNEQ, has entered a master distributor agreement with AD Ports Logistics (ADPL).
ADPL is a subsidiary of the Logistics Cluster, AD Ports Group, a global facilitator of trade, logistics and industry based in Abu Dhabi.
The master distributor agreement covers the distribution of ZTlido in the UAE, Qatar, Bahrain, Kuwait, Oman, and Egypt.
ZTlido is a lidocaine topical system approved for relieving neuropathic pain associated with post-herpetic neuralgia (PHN).
CH Trading Group LLC will continue the process to expand the commercialization of ZTlido in the Middle East and North Africa markets.
Price Action: SCLX shares are trading higher by 5.87% at $14.25 on the last check Monday.